Levoketoconazole Patent Expiration

Levoketoconazole is used for treating Cushing's syndrome in patients with endogenous hypercortisolemia, when surgery is not an option or has not been curative. It was first introduced by Strongbridge Dublin Ltd in its drug Recorlev on Dec 30, 2021.


Levoketoconazole Patents

Given below is the list of patents protecting Levoketoconazole, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Recorlev US10098877 Methods and compositions for treating diabetes, metabolic syndrome and other conditions Jan 10, 2026 Strongbridge
Recorlev US10517868 Methods and compositions for treating diabetes, metabolic syndrome and other conditions Jan 10, 2026 Strongbridge
Recorlev US10835530 Methods and compositions for treating diabetes, metabolic syndrome and other conditions Jan 10, 2026 Strongbridge
Recorlev US11020393 Methods of treating disease with levoketoconazole Mar 02, 2040 Strongbridge
Recorlev US11278547 Methods of treating disease with levoketoconazole Mar 02, 2040 Strongbridge
Recorlev US11478471 Methods and compositions for treating diabetes, metabolic syndrome and other conditions Jan 10, 2026 Strongbridge
Recorlev US11903940 Methods of treating disease with levoketoconazole Mar 02, 2040 Strongbridge
Recorlev US9918984 Methods and compositions for treating diabetes, metabolic syndrome and other conditions Jan 10, 2026 Strongbridge


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Levoketoconazole's patents.

Given below is the list recent legal activities going on the following patents of Levoketoconazole.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 06 May, 2024 US10835530
transaction for FDA Determination of Regulatory Review Period 29 Feb, 2024 US9918984
Patent Issue Date Used in PTA Calculation 20 Feb, 2024 US11903940
Recordation of Patent eGrant 20 Feb, 2024 US11903940
Recordation of Patent Grant Mailed 20 Feb, 2024 US11903940
Mail Patent eGrant Notification 20 Feb, 2024 US11903940
Patent eGrant Notification 20 Feb, 2024 US11903940
Email Notification 20 Feb, 2024 US11903940
Email Notification 01 Feb, 2024 US11903940
Issue Notification Mailed 31 Jan, 2024 US11903940



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳